BRPI0407306A - 1,2,4- triazinas de inibição de hiv - Google Patents
1,2,4- triazinas de inibição de hivInfo
- Publication number
- BRPI0407306A BRPI0407306A BRPI0407306-1A BRPI0407306A BRPI0407306A BR PI0407306 A BRPI0407306 A BR PI0407306A BR PI0407306 A BRPI0407306 A BR PI0407306A BR PI0407306 A BRPI0407306 A BR PI0407306A
- Authority
- BR
- Brazil
- Prior art keywords
- hiv
- triazines
- inhibiting
- triazins
- remedy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furnace Details (AREA)
Abstract
"1,2,4-TRIAZINAS DE INIBIçãO DE HIV". A presente invenção refere-se a inibidores de replicação de HIV da fórmula (1) como definido no relatório descritivo, seu uso como um remédio, seus processos para a preparação e composições farmacêuticas compreendendo-os.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP0301289 | 2003-02-07 | ||
PCT/EP2004/050084 WO2004074266A1 (en) | 2003-02-07 | 2004-02-05 | Hiv inhibiting 1,2,4-triazines |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0407306A true BRPI0407306A (pt) | 2006-02-21 |
Family
ID=32892827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0407306-1A BRPI0407306A (pt) | 2003-02-07 | 2004-02-05 | 1,2,4- triazinas de inibição de hiv |
Country Status (20)
Country | Link |
---|---|
US (1) | US7585861B2 (pt) |
EP (1) | EP1597242B1 (pt) |
JP (1) | JP4783725B2 (pt) |
KR (1) | KR20050105190A (pt) |
CN (2) | CN1747941A (pt) |
AP (1) | AP2005003365A0 (pt) |
AT (1) | ATE402152T1 (pt) |
AU (1) | AU2004213173B2 (pt) |
BR (1) | BRPI0407306A (pt) |
CA (1) | CA2513123C (pt) |
DE (1) | DE602004015254D1 (pt) |
EA (1) | EA010379B1 (pt) |
ES (1) | ES2311146T3 (pt) |
HR (1) | HRP20050690A2 (pt) |
IL (1) | IL170120A (pt) |
MX (1) | MXPA05008368A (pt) |
NO (1) | NO20054127L (pt) |
PL (1) | PL232814B1 (pt) |
WO (1) | WO2004074266A1 (pt) |
ZA (1) | ZA200506254B (pt) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2567574C (en) | 2004-04-08 | 2013-01-08 | Targegen, Inc. | Benzotriazine inhibitors of kinases |
US7923554B2 (en) * | 2004-08-10 | 2011-04-12 | Janssen Pharmaceutica N.V. | HIV inhibiting 1,2,4-triazin-6-one derivatives |
WO2006024034A1 (en) | 2004-08-25 | 2006-03-02 | Targegen, Inc. | Heterocyclic compounds and methods of use |
AU2005286648A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
BRPI0515478A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e seu uso como mediadores de estearoil-coa-desaturase |
BRPI0515483A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase |
CA2580762A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as therapeutic agents |
WO2006101521A2 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
MX2007003325A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores estearoil-coa-desaturasa. |
CA2580845A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
CN101208089A (zh) | 2005-06-03 | 2008-06-25 | 泽农医药公司 | 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 |
NZ567851A (en) | 2005-11-01 | 2011-09-30 | Targegen Inc | Bi-aryl meta-pyrimidine inhibitors of kinases |
US8604042B2 (en) | 2005-11-01 | 2013-12-10 | Targegen, Inc. | Bi-aryl meta-pyrimidine inhibitors of kinases |
US8133900B2 (en) | 2005-11-01 | 2012-03-13 | Targegen, Inc. | Use of bi-aryl meta-pyrimidine inhibitors of kinases |
JP2010518014A (ja) * | 2007-01-31 | 2010-05-27 | バーテックス ファーマシューティカルズ インコーポレイテッド | キナーゼ阻害剤として有用な2−アミノピリジン誘導体 |
KR101781605B1 (ko) | 2008-05-21 | 2017-09-25 | 어리어드 파마슈티칼스, 인코포레이티드 | 키나아제 억제제로서 포스포러스 유도체 |
AU2009274011B2 (en) | 2008-07-23 | 2014-12-18 | Vertex Pharmaceuticals Incorporated | Pyrazolopyridine kinase inhibitors |
US8569337B2 (en) | 2008-07-23 | 2013-10-29 | Vertex Pharmaceuticals Incorporated | Tri-cyclic pyrazolopyridine kinase inhibitors |
CN102131809A (zh) | 2008-07-23 | 2011-07-20 | 沃泰克斯药物股份有限公司 | 三环吡唑并吡啶激酶抑制剂 |
CN102159546A (zh) * | 2008-08-06 | 2011-08-17 | 沃泰克斯药物股份有限公司 | 氨基吡啶激酶抑制剂 |
MX2011011653A (es) | 2009-05-06 | 2012-01-20 | Vertex Pharma | Pirazolopiridinas. |
EP2550272A1 (en) | 2010-01-27 | 2013-01-30 | Vertex Pharmaceuticals Incorporated | Pyrazolopyrazine kinase inhibitors |
AU2011209651A1 (en) | 2010-01-27 | 2012-08-09 | Vertex Pharmaceuticals Incorporated | Pyrazolopyrimidine kinase inhibitors |
AU2011209726A1 (en) | 2010-01-27 | 2012-08-09 | Vertex Pharmaceuticals Incorporated | Pyrazolopyridine kinase inhibitors |
AU2010363329A1 (en) | 2010-11-07 | 2013-05-09 | Targegen, Inc. | Compositions and methods for treating myelofibrosis |
US20170298055A1 (en) | 2014-09-17 | 2017-10-19 | Ironwood Pharmaceuticals, Inc. | sGC STIMULATORS |
PL3464272T3 (pl) | 2016-06-07 | 2022-03-28 | Jacobio Pharmaceuticals Co., Ltd. | Nowe pochodne heterocykliczne użyteczne jako inhibitory SHP2 |
TWI664175B (zh) | 2017-03-23 | 2019-07-01 | 大陸商北京加科思新藥研發有限公司 | 用於作為shp2抑制劑之新穎雜環衍生物 |
WO2021071984A1 (en) * | 2019-10-08 | 2021-04-15 | Skyhawk Therapeutics, Inc. | Compounds for modulating splicing |
BR112022011917A2 (pt) | 2019-12-20 | 2022-09-06 | Tenaya Therapeutics Inc | Fluoroalquil-oxadiazois e seus usos |
CN111333543B (zh) * | 2020-04-17 | 2022-09-16 | 武汉工程大学 | 一种利匹韦林中间体的合成方法 |
CN115745848A (zh) * | 2022-12-07 | 2023-03-07 | 上海优合生物科技有限公司 | 一种氨基胍的加工合成工艺 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3459731A (en) | 1966-12-16 | 1969-08-05 | Corn Products Co | Cyclodextrin polyethers and their production |
IL123654A (en) | 1995-11-23 | 2001-08-08 | Janssen Pharmaceutica Nv | Process for the preparation of solid mixtures of cyclodextrins and pharmaceutical preparations containing such solid mixtures |
NO311614B1 (no) * | 1996-10-01 | 2001-12-17 | Janssen Pharmaceutica Nv | Substituerte diamino-1,3,5-triazinderivater |
EP0945447A1 (en) * | 1998-03-27 | 1999-09-29 | Janssen Pharmaceutica N.V. | Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections |
AP1468A (en) * | 1998-03-27 | 2005-09-23 | Janssen Pharmaceutica Nv | Hiv inhibiting pyrimidine derivatives. |
CN1295567A (zh) | 1998-03-27 | 2001-05-16 | 株式会社Lg化学 | 作为新型抗氧剂的聚乙氧基化抗坏血酸衍生物及其制备方法 |
SK287269B6 (sk) * | 1998-11-10 | 2010-05-07 | Janssen Pharmaceutica N. V. | Derivát pyrimidínu, jeho použitie, spôsob jeho prípravy a farmaceutická kompozícia, kombinácia a produkt s jeho obsahom |
CA2351203C (en) * | 1998-11-10 | 2009-03-24 | Janssen Pharmaceutica N.V. | 2,4-disubstituted triazine derivatives with anti hiv activity |
ES2542326T3 (es) * | 2000-05-08 | 2015-08-04 | Janssen Pharmaceutica Nv | Inhibidores de la replicación del VIH |
US7105522B2 (en) * | 2001-03-15 | 2006-09-12 | Janssen Pharmaceutica, N.V. | HIV inhibiting pyrazinone derivatives |
JO3429B1 (ar) | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
-
2004
- 2004-02-05 MX MXPA05008368A patent/MXPA05008368A/es active IP Right Grant
- 2004-02-05 AP AP2005003365A patent/AP2005003365A0/xx unknown
- 2004-02-05 AU AU2004213173A patent/AU2004213173B2/en not_active Ceased
- 2004-02-05 CN CNA2004800035861A patent/CN1747941A/zh active Pending
- 2004-02-05 CA CA2513123A patent/CA2513123C/en not_active Expired - Fee Related
- 2004-02-05 DE DE602004015254T patent/DE602004015254D1/de not_active Expired - Lifetime
- 2004-02-05 EA EA200501268A patent/EA010379B1/ru not_active IP Right Cessation
- 2004-02-05 US US10/544,584 patent/US7585861B2/en not_active Expired - Lifetime
- 2004-02-05 BR BRPI0407306-1A patent/BRPI0407306A/pt not_active IP Right Cessation
- 2004-02-05 EP EP04708367A patent/EP1597242B1/en not_active Expired - Lifetime
- 2004-02-05 ES ES04708367T patent/ES2311146T3/es not_active Expired - Lifetime
- 2004-02-05 JP JP2006502005A patent/JP4783725B2/ja not_active Expired - Fee Related
- 2004-02-05 WO PCT/EP2004/050084 patent/WO2004074266A1/en active IP Right Grant
- 2004-02-05 CN CN201110305993XA patent/CN102503903A/zh active Pending
- 2004-02-05 PL PL378107A patent/PL232814B1/pl unknown
- 2004-02-05 KR KR1020057013955A patent/KR20050105190A/ko not_active Application Discontinuation
- 2004-02-05 AT AT04708367T patent/ATE402152T1/de not_active IP Right Cessation
-
2005
- 2005-08-01 HR HR20050690A patent/HRP20050690A2/xx not_active Application Discontinuation
- 2005-08-04 IL IL170120A patent/IL170120A/en active IP Right Grant
- 2005-08-04 ZA ZA200506254A patent/ZA200506254B/en unknown
- 2005-09-05 NO NO20054127A patent/NO20054127L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE402152T1 (de) | 2008-08-15 |
MXPA05008368A (es) | 2005-11-04 |
US20070037811A1 (en) | 2007-02-15 |
JP4783725B2 (ja) | 2011-09-28 |
PL232814B1 (pl) | 2019-07-31 |
JP2006516983A (ja) | 2006-07-13 |
CA2513123A1 (en) | 2004-09-02 |
WO2004074266A8 (en) | 2004-11-11 |
AP2005003365A0 (en) | 2005-09-30 |
AU2004213173B2 (en) | 2010-07-29 |
KR20050105190A (ko) | 2005-11-03 |
US7585861B2 (en) | 2009-09-08 |
CN1747941A (zh) | 2006-03-15 |
CN102503903A (zh) | 2012-06-20 |
ES2311146T3 (es) | 2009-02-01 |
EP1597242B1 (en) | 2008-07-23 |
NO20054127L (no) | 2005-09-05 |
EA200501268A1 (ru) | 2006-02-24 |
AU2004213173A1 (en) | 2004-09-02 |
ZA200506254B (en) | 2008-02-27 |
PL378107A1 (pl) | 2006-03-06 |
DE602004015254D1 (de) | 2008-09-04 |
EA010379B1 (ru) | 2008-08-29 |
WO2004074266A1 (en) | 2004-09-02 |
IL170120A (en) | 2013-04-30 |
EP1597242A1 (en) | 2005-11-23 |
CA2513123C (en) | 2013-04-23 |
HRP20050690A2 (en) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0407306A (pt) | 1,2,4- triazinas de inibição de hiv | |
BRPI0407741B8 (pt) | pirimidinas e triazinas de inibição de replicação de hiv | |
CO5640037A2 (es) | Derivados de la quinazolina para el tratamiento del cancer | |
BR0213562A (pt) | Benzimidazóis e análogos e seu uso como inibidores de cinases de proteìna | |
BRPI0408347B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
BRPI0213522C1 (pt) | compostos derivados de hidroxipirimidinona, composição farmacêutica, e, uso de um composto | |
UY30942A1 (es) | Nuevos derivados de 3-([1,2,4,]triazolo[4,3-a]piridin-7-il)benzamida | |
BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0720270B8 (pt) | compostos 4-fenil-6-(2,2,2-triflúor-1-fenil etoxi) pirimidina, composição e forma de dosagem sólida | |
ECSP10010197A (es) | Derivados de piridina y pirazina útiles en el tratamiento de trastornos de proliferación celular | |
UY27714A1 (es) | 2 - heteroaril - pirimidinas inhibidoras de cdk, su preparación y su uso como medicamentos. | |
BRPI0508876A (pt) | pró medicamentos de agentes antivirais de piperazina e piperidina substituìda | |
UY30759A1 (es) | Compuestos quimicos | |
BRPI0718813B8 (pt) | compostos derivados de 1,1-dióxido de 1,4-benzotiepina, medicamento que os compreendem e seus usos | |
EA200601654A1 (ru) | Ингибиторы интегразы вич | |
BRPI0806863B8 (pt) | uso de um éster de forbol na preparação de um medicamento para prevenção ou tratamento de uma infecção por hiv | |
TW200800931A (en) | Novel piperazines as antimalarial agents | |
UY30544A1 (es) | Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones | |
BRPI0816798A2 (pt) | composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação | |
ATE372995T1 (de) | Benzo(b)(1,4)dioxepinderivate | |
BRPI0414948A (pt) | derivados de pirazolo-e-imidazo pirimidina | |
WO2006042478A8 (fr) | Inhibiteurs de petites molecules de la protease principale des coronavirus, leur preparation et utilisation | |
UY30847A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales | |
UY29358A1 (es) | Tiazolidinonas, su preparacion y su uso como medicamento | |
BR0210548A (pt) | éteres aromáticos substituìdos como inibidores do transporte de glicina e composição farmacêutica aque os compreende |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |